Page last updated: 2024-10-24

cgp 12177 and Hypothyroidism

cgp 12177 has been researched along with Hypothyroidism in 1 studies

CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Germack, R1
Starzec, A1
Perret, GY1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study[NCT00312715]41 participants (Actual)Observational2006-04-03Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for cgp 12177 and Hypothyroidism

ArticleYear
Regulation of beta 1- and beta 3-adrenergic agonist-stimulated lipolytic response in hyperthyroid and hypothyroid rat white adipocytes.
    British journal of pharmacology, 2000, Volume: 129, Issue:3

    Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; An

2000